SPONSOR
Zhejiang University
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 1, EARLY_Phase 1
Conditions studied: Liver DiseasesSurgeryProstate Cancer (Post Prostatectomy)Perioperative AnestheticCatheter-related Bladder Discomfort (CRBD)Large B-Cell Lymphoma (LBCL)Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard TreatmentsHematologic DiseasesNeoplasmsSystemic Lupus Erythematosus
Zhejiang University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Liver Diseases, Surgery, Prostate Cancer (Post Prostatectomy), Perioperative Anesthetic.
The trial portfolio spans Phase 2, Phase 1, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhejiang University
How many clinical trials has Zhejiang University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Zhejiang University, of which 7 are actively recruiting participants. These trials cover conditions including Liver Diseases, Surgery, Prostate Cancer (Post Prostatectomy). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhejiang University research focus on?
Zhejiang University clinical trials span Liver Diseases, Surgery, Prostate Cancer (Post Prostatectomy), Perioperative Anesthetic, Catheter-related Bladder Discomfort (CRBD), and additional conditions. The research pipeline includes Phase 2, Phase 1, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhejiang University clinical trial?
To participate in a Zhejiang University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhejiang University trials with current recruitment status updated daily.
Clinical Trials by Zhejiang University
NCT06353672
Recruiting
A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
Liver Diseases
NCT07607990
Recruiting
Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP
Prostate Cancer (Post Prostatectomy)
NCT04661020 Phase 2
Recruiting
CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma
Large B-Cell Lymphoma (LBCL)
NCT07021534 Phase 1
Recruiting
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments
NCT07257640 Phase 1
Recruiting
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
Hematologic Diseases
NCT06711146 EARLY_Phase 1
Recruiting
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
Systemic Lupus Erythematosus
NCT07307560
Recruiting
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Hypoxia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology